Previous Close | 34.47 |
Open | 34.32 |
Bid | 34.96 x 1000 |
Ask | 34.97 x 1000 |
Day's Range | 33.92 - 35.07 |
52 Week Range | 21.36 - 39.00 |
Volume | |
Avg. Volume | 997,701 |
Market Cap | 3.208B |
Beta (5Y Monthly) | 1.86 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.38 |
Earnings Date | Nov 01, 2022 - Nov 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 46.14 |
Subscribe to Yahoo Finance Plus to view Fair Value for EVH
Does Evolent Health (EVH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley and Vice President, Investor Relations Seth Frank will conduct investor meetings and host a presentation at the Canaccord Genuity 42nd Annual Growth Conference at The Intercontinental Boston Hotel, Boston, Mass., on Wednesday, August 10, 2022 at 4:30 p.m. ET.
The consensus price target hints at a 28.3% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.